Method of treatment of chronic purulent inflammations of ear in

Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Alkali or alkaline earth chloride

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241641, 424520, 424529, 424530, 424531, A61K 3314, A61K 3516

Patent

active

053975782

ABSTRACT:
A method for treating chronic, purulent, middle otitis in children, comprising administering, through a perforation into a middle ear cavity, a freshly prepared donor plasma of one of the parents having the identical blood group to fill up the cavity (1,5-2,0 ml 3-4 times within 24 hours with the preliminary washing of the cavity with a physiological solution prior to each administration.

REFERENCES:
Fedorova et al SU 1560199 (Apr. 30, 1990).
Alekseera et al SU 1197672 (Dec. 15, 1985).
Bikbaeva et al SU 1242179 (Jul. 7,1986).
Shurin et al J. Pediatr. 123(5). 739-741 Nov. 1993.
Stever et al Oto-Rhino-Laryneol Nova 4/2: 76-81(1994).
Griguryer et al USSR Vestn. Ottoringlaringol 43/2: 13-15(1981).
Brief Medical Encyclopaedia, Moscow, vol. 2, p. 314 in Russian & English (1989).
Hypoacusis, p. 383 in Russian & English (1978).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treatment of chronic purulent inflammations of ear in does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of chronic purulent inflammations of ear in , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of chronic purulent inflammations of ear in will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-712213

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.